# AI DDDD 360™ — Evidence Model Scope

## Project Identity

- Project: AI DDDD 360™
- Full Name: Universal AI Drug Discovery & Development Intelligence Platform
- Version: 0.1.0
- Environment: Google Colab
- Persistent Storage: Google Drive
- Architecture: Disease-Agnostic
- Primary Validation Disease: Parkinson's Disease

## Step 4 — Evidence model

### Step 4 Scope

This artifact defines the evidence-model scope derived from the
AI DDDD 360™ Master Control.

It is a scope and requirements artifact. It does not finalize a
database schema, serialization format, ontology implementation,
identifier system, or software architecture.

## Evidence Hierarchy

The evidence model shall preserve the following evidence hierarchy:

- E0 — No evidence
- E1 — Computational prediction
- E2 — Molecular / biochemical evidence
- E3 — Cellular evidence
- E4 — Animal / preclinical evidence
- E5 — Human observational evidence
- E6 — Clinical trial evidence
- E7 — Regulatory / validated clinical evidence

## Evidence Provenance

Evidence provenance is a required component of the evidence model.

The system must preserve the provenance associated with evidence so
that evidence supporting a conclusion remains traceable.

## Evidence Distinction

The system must never silently treat E1 evidence as equivalent to E6 evidence.

Computational prediction and clinical trial evidence must therefore
remain explicitly distinguishable within the evidence model.

## Evidence and Scientific Reasoning

The evidence model must support the scientific questions defined by
the Master Control, including:

1. What evidence supports each conclusion?
2. What evidence conflicts?

The evidence model must therefore preserve the distinction between
supporting and conflicting evidence rather than collapsing evidence
into an undifferentiated collection.

## Uncertainty and Biology Deficit

The Evidence Model scope must preserve scientific uncertainty and
evidence interpretation.

Biology Deficit is a defined scientific concept in the Master Control
and must remain traceable within the evidence model scope.

The evidence model must also preserve the scientific question:

"What is the highest-information next step?"

No uncertainty score, confidence formula, or other quantitative
uncertainty algorithm is defined by this scope artifact.


Evidence convergence is also a defined evidence-related requirement in the Master Control and must be preserved in the Evidence Model scope.

## Scope Boundary

This Step 4 scope artifact does NOT finalize:

- detailed database fields
- database schema
- identifier conventions
- ontology implementation
- serialization format
- storage technology
- retrieval technology
- scoring formula
- evidence-weighting algorithm
- confidence calculation
- machine-learning model
- agent implementation

Such implementation decisions require explicit verification against
the Master Control and subsequent project requirements.

## Traceability

Primary source:

AI_DDDD_360_MASTER_CONTROL.md

Relevant source requirements include:

- Evidence hierarchy
- Evidence provenance
- Supporting evidence
- Conflicting evidence
- E1 versus E6 distinction
- Scientific uncertainty and evidence interpretation

## Capture Metadata

Created: 2026-09-29T07:16:14.795472+00:00
Source: AI_DDDD_360_MASTER_CONTROL.md
Step: 4 — Evidence model

## Reproducibility Requirement

Any future modification to this scope must preserve source
traceability and be validated before Step 4 progression.

The Evidence Model must preserve the reproducibility context
required by the Master Control, including:

- Project version
- Software versions
- Configuration
- Data and evidence provenance
- Experiment ID where applicable
- Model version
- Prompt/context version where applicable
- Seed where applicable
- Temporal cutoff
- Evaluation dataset where applicable
- Git commit
- Results
- Interpretation
- Limitations

## Scientific Safety Requirements

- Preserve uncertainty.

- Maintain human oversight.
- Distinguish evidence from inference.
- Distinguish hypothesis from demonstrated effect.
